Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population

Shu Li Wang, Huei Lee, Kuo Wen Chen, Kan Jen Tsai, Chih Yi Chen, Pinpin Lin

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Cytochrome P4502E1 (CYP2E1) is involved in metabolic activation of carcinogenic nitrosamines, benzene and low molecular weight halogenated hydrocarbons. In this study, we assessed the association between CYP2E1 RsaI and DraI genetic polymorphisms and lung cancer in a Taiwanese population. The RsaI genotype distribution was significantly different between 119 lung cancer patients and 231 non-cancer controls. The homozygote variants of RsaI genotypes were more common in controls (6.9%) than in lung cancer patients (0.8%). The estimated odds ratio (OR) was 0.11 (95% confidence interval (CI), 0.01-0.87). After adjusting for age, sex, and smoking status, the OR was 0.12 (95% CI, 0.02-0.95). This is the first observation of a positive association between this locus and lung cancer in an Asian population. No significant differences in CYP2E1 DraI genotype distributions were found between cases and controls. The results of this study indicate that CYP2E1 RsaI polymorphism, but not DraI polymorphism, may contribute to the development of lung cancer in Taiwan.

Original languageEnglish
Pages (from-to)27-34
Number of pages8
JournalLung Cancer
Volume26
Issue number1
DOIs
Publication statusPublished - Oct 1999
Externally publishedYes

Fingerprint

Genetic Polymorphisms
Cytochromes
Lung Neoplasms
Population
Genotype
Odds Ratio
Halogenated Hydrocarbons
Confidence Intervals
Nitrosamines
Homozygote
Benzene
Taiwan
Molecular Weight
Smoking
Observation

Keywords

  • Cytochrome P4502E1
  • Genetic polymorphism
  • Lung cancer
  • Odds ratio
  • Taiwan

ASJC Scopus subject areas

  • Oncology

Cite this

Wang, S. L., Lee, H., Chen, K. W., Tsai, K. J., Chen, C. Y., & Lin, P. (1999). Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. Lung Cancer, 26(1), 27-34. https://doi.org/10.1016/S0169-5002(99)00070-7

Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. / Wang, Shu Li; Lee, Huei; Chen, Kuo Wen; Tsai, Kan Jen; Chen, Chih Yi; Lin, Pinpin.

In: Lung Cancer, Vol. 26, No. 1, 10.1999, p. 27-34.

Research output: Contribution to journalArticle

Wang, SL, Lee, H, Chen, KW, Tsai, KJ, Chen, CY & Lin, P 1999, 'Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population', Lung Cancer, vol. 26, no. 1, pp. 27-34. https://doi.org/10.1016/S0169-5002(99)00070-7
Wang, Shu Li ; Lee, Huei ; Chen, Kuo Wen ; Tsai, Kan Jen ; Chen, Chih Yi ; Lin, Pinpin. / Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. In: Lung Cancer. 1999 ; Vol. 26, No. 1. pp. 27-34.
@article{cf776e4a61a24d599bc8f0ca6dda30cd,
title = "Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population",
abstract = "Cytochrome P4502E1 (CYP2E1) is involved in metabolic activation of carcinogenic nitrosamines, benzene and low molecular weight halogenated hydrocarbons. In this study, we assessed the association between CYP2E1 RsaI and DraI genetic polymorphisms and lung cancer in a Taiwanese population. The RsaI genotype distribution was significantly different between 119 lung cancer patients and 231 non-cancer controls. The homozygote variants of RsaI genotypes were more common in controls (6.9{\%}) than in lung cancer patients (0.8{\%}). The estimated odds ratio (OR) was 0.11 (95{\%} confidence interval (CI), 0.01-0.87). After adjusting for age, sex, and smoking status, the OR was 0.12 (95{\%} CI, 0.02-0.95). This is the first observation of a positive association between this locus and lung cancer in an Asian population. No significant differences in CYP2E1 DraI genotype distributions were found between cases and controls. The results of this study indicate that CYP2E1 RsaI polymorphism, but not DraI polymorphism, may contribute to the development of lung cancer in Taiwan.",
keywords = "Cytochrome P4502E1, Genetic polymorphism, Lung cancer, Odds ratio, Taiwan",
author = "Wang, {Shu Li} and Huei Lee and Chen, {Kuo Wen} and Tsai, {Kan Jen} and Chen, {Chih Yi} and Pinpin Lin",
year = "1999",
month = "10",
doi = "10.1016/S0169-5002(99)00070-7",
language = "English",
volume = "26",
pages = "27--34",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population

AU - Wang, Shu Li

AU - Lee, Huei

AU - Chen, Kuo Wen

AU - Tsai, Kan Jen

AU - Chen, Chih Yi

AU - Lin, Pinpin

PY - 1999/10

Y1 - 1999/10

N2 - Cytochrome P4502E1 (CYP2E1) is involved in metabolic activation of carcinogenic nitrosamines, benzene and low molecular weight halogenated hydrocarbons. In this study, we assessed the association between CYP2E1 RsaI and DraI genetic polymorphisms and lung cancer in a Taiwanese population. The RsaI genotype distribution was significantly different between 119 lung cancer patients and 231 non-cancer controls. The homozygote variants of RsaI genotypes were more common in controls (6.9%) than in lung cancer patients (0.8%). The estimated odds ratio (OR) was 0.11 (95% confidence interval (CI), 0.01-0.87). After adjusting for age, sex, and smoking status, the OR was 0.12 (95% CI, 0.02-0.95). This is the first observation of a positive association between this locus and lung cancer in an Asian population. No significant differences in CYP2E1 DraI genotype distributions were found between cases and controls. The results of this study indicate that CYP2E1 RsaI polymorphism, but not DraI polymorphism, may contribute to the development of lung cancer in Taiwan.

AB - Cytochrome P4502E1 (CYP2E1) is involved in metabolic activation of carcinogenic nitrosamines, benzene and low molecular weight halogenated hydrocarbons. In this study, we assessed the association between CYP2E1 RsaI and DraI genetic polymorphisms and lung cancer in a Taiwanese population. The RsaI genotype distribution was significantly different between 119 lung cancer patients and 231 non-cancer controls. The homozygote variants of RsaI genotypes were more common in controls (6.9%) than in lung cancer patients (0.8%). The estimated odds ratio (OR) was 0.11 (95% confidence interval (CI), 0.01-0.87). After adjusting for age, sex, and smoking status, the OR was 0.12 (95% CI, 0.02-0.95). This is the first observation of a positive association between this locus and lung cancer in an Asian population. No significant differences in CYP2E1 DraI genotype distributions were found between cases and controls. The results of this study indicate that CYP2E1 RsaI polymorphism, but not DraI polymorphism, may contribute to the development of lung cancer in Taiwan.

KW - Cytochrome P4502E1

KW - Genetic polymorphism

KW - Lung cancer

KW - Odds ratio

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=0033214376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033214376&partnerID=8YFLogxK

U2 - 10.1016/S0169-5002(99)00070-7

DO - 10.1016/S0169-5002(99)00070-7

M3 - Article

C2 - 10574678

AN - SCOPUS:0033214376

VL - 26

SP - 27

EP - 34

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 1

ER -